The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study.
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Ignyta; Mirati Therapeutics
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics
 
Marcelo Raul Bonomi
Research Funding - EpicentRx (Inst)
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio; Lilly
Research Funding - Daiichi Sankyo; Infinity Pharmaceuticals; Seagen; Vaccinex
 
Michael J. Schell
No Relationships to Disclose
 
Jiannong Li
No Relationships to Disclose
 
Matthew Johnson
No Relationships to Disclose
 
Jude Masannat
No Relationships to Disclose
 
Juan C. Hernandez-Prera
No Relationships to Disclose
 
Caitlin McMullen
No Relationships to Disclose
 
J Wadsworth
No Relationships to Disclose
 
Krupal Patel
No Relationships to Disclose
 
Julie Ann Kish
No Relationships to Disclose
 
Jameel Muzaffar
No Relationships to Disclose
 
Kedar Kirtane
No Relationships to Disclose
 
James William Rocco
No Relationships to Disclose
 
Nabil F. Saba
Honoraria - Aduro Biotech; Bristol-Myers Squibb; CUE Biopharma; Genentech/Roche; GlaxoSmithKline; Kura Oncology; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Lilly; Merck; Pfizer